Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Shares Outstanding (2016 - 2022)

Edesa Biotech's Shares Outstanding history spans 9 years, with the latest figure at $15.5 million for Q2 2022.

  • For Q2 2022, Shares Outstanding rose 16.65% year-over-year to $15.5 million; the TTM value through Jun 2022 reached $15.5 million, up 16.65%, while the annual FY2021 figure was $1.9 million, 80.25% down from the prior year.
  • Shares Outstanding for Q2 2022 was $15.5 million at Edesa Biotech, roughly flat from $15.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $15.5 million in Q1 2022 and bottomed at $1.9 million in Q3 2021.
  • The 5-year median for Shares Outstanding is $8.2 million (2019), against an average of $8.0 million.
  • The largest annual shift saw Shares Outstanding surged 645.12% in 2019 before it tumbled 80.25% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $1.0 million in 2018, then soared by 645.12% to $7.5 million in 2019, then soared by 40.22% to $10.5 million in 2020, then tumbled by 81.95% to $1.9 million in 2021, then skyrocketed by 714.09% to $15.5 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Shares Outstanding are $15.5 million (Q2 2022), $15.5 million (Q1 2022), and $1.9 million (Q3 2021).